I-125 Rapid Strand(TM) loading technique

Radiation Oncology Investigations

Volumn 4, Issue 1, 1996, Pages 48-49

  Butler, Wayne M ^a   Merrick, Gregory S ^a,b  

^a WHEELING HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anusol; brachytherapy; prostate; Rapid Strand(TM)

Indexed keywords

HYDROCORTISONE; HYDROCORTISONE ACETATE; IODINE 125;

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECTAL DRUG ADMINISTRATION;

EID: 0029894993     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1996)4:1<48::AID-ROI8>3.0.CO;2-M     Document Type: Article

References (3)

1. Grimm PD, Blasko JC, Ragde H: Ultrasound guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early stage prostate cancer. Atlas Urol Clin North Am 2:113-125, 1994.
2. Blasko JC, Ragde H, Schumacher D: Transperineal percutaneous iodine-125 implantation forprostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether Hyperthermia Oncol 3:131-139, 1987.
3. Blasko JC, Wallner K, Grimm PD, Ragde H: Prostate specific antigen based disease control following ultrasound guided iodine-125 implantation for stage T1/T2 prostatic carcinoma. J Urol 154:1096-1099, 1995.